Welcome to our dedicated page for GridAI Technologies SEC filings (Ticker: GRDX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
GridAI Technologies Corp. filings document the formal reporting record for a Nasdaq Capital Market issuer that shifted from Entero Therapeutics into a diversified technology and life sciences company after the Grid AI acquisition. The filings identify GRDX common stock, material-event reports, operating and financial results, capital-structure matters, governance disclosures, shareholder voting matters, risk factors, and material agreements.
Recent 8-K disclosures also record Nasdaq periodic-reporting compliance matters tied to a delayed Form 10-K and the subsequent closure of that issue, as well as direct financial-obligation events under a revolving loan agreement. The filing record connects the company's energy-orchestration operations, legacy gastrointestinal therapeutics activities, financing arrangements, and public-company reporting obligations.
GridAI Technologies Corp. (GRDX) filed an amended quarterly report for the period ended June 30, 2026 to revise and expand its goodwill and critical accounting policy disclosures after SEC staff comments. The amendment clarifies the qualitative description of goodwill from the Grid AI Corp. acquisition, the valuation method for the AI reporting unit, and key assumptions used in impairment testing, but it does not change any previously reported financial statement amounts, including the goodwill impairment charge.
For the six months ended June 30, 2026, GridAI reported revenue of $124,084 and a net loss of $16.5 million, driven largely by a $10.1 million goodwill impairment on the AI reporting unit and high general and administrative expenses. Cash and cash equivalents were about $1.4 million, with a working capital deficit of roughly $11.8 million and an accumulated deficit of about $224.9 million, and management disclosed substantial doubt about the company’s ability to continue as a going concern.
Total assets were $37.0 million, including $14.0 million of goodwill and $20.7 million of finite-lived intangibles related mainly to the Grid AI acquisition, while total liabilities were $18.3 million and stockholders’ equity was $14.9 million. During the first half of 2026 the company raised funding through equity offerings and warrant exercises, increased common shares outstanding to 6,913,198, and continued operating two segments: its legacy gastrointestinal therapeutics business and its newer AI-driven energy optimization platform.
GridAI Technologies Corp. (GRDX) disclosed that on September 4, 2026 it entered into an Amended and Restated Secured Convertible Promissory Note with Pronghorn Resources, LLC, updating a prior $2,000,000 note to reflect a second, additional loan of $964,000.
The Parties also executed a First Amendment to the Security Agreement, revising the definition of “Note” so that the security package now applies to the Amended and Restated Secured Convertible Promissory Note. Both amended agreements are filed as exhibits and incorporated by reference.
GridAI Technologies Corp. (GRDX) filed an amended S-1 to register for resale up to 9,908,766 shares of common stock held by selling stockholders, including shares issuable on exercise of Pre-funded Warrants and Common Warrants from May and July 2026 private placements. GridAI itself is not selling shares and will only receive cash if warrants are exercised for cash.
The company focuses on AI-driven energy orchestration for data centers via Grid AI Corp. and legacy GI drug candidate Adrulipase. As of June 30, 2026, GridAI had $1.4 million in cash, an accumulated deficit of $224.9 million, negative working capital of $11.8 million, a $10.1 million goodwill impairment, and a forecast annual cash burn of $7.8 million. Auditors have expressed substantial doubt about its ability to continue as a going concern.
GridAI has raised or arranged gross proceeds of about $12.5 million across three 2026 private placements, with $4 million already received and $12.3 million contractually to be paid before this registration is effective. If the registration is not declared effective by January 2027, or if additional funding is not obtained, the company states it may need to curtail or cease operations, liquidate, or seek bankruptcy protection. Full conversion of its Series H preferred stock, if milestones and stockholder approval are achieved, would dilute pre-acquisition stockholders’ ownership by about 84.5%.
GridAI Technologies Corp. (GRDX) reports very early-stage revenue and large losses for the six months ended June 30, 2026. Revenue was $124,084 with a gross loss of $650,254, while total operating expenses reached $16,071,004, including a $10,070,124 goodwill impairment related to the 2025 Grid AI acquisition.
Loss from continuing operations was $16,478,995, and net loss applicable to common shareholders was $16,307,455, or $(2.81) per share. Total assets declined to $37,035,600 from $48,551,843 at year-end, with $14,048,553 of goodwill and $20,687,863 of finite-lived intangibles (developed technology, customer relationships and trade name).
Liquidity is strained: cash and cash equivalents were approximately $1.4 million, with a working capital deficit of approximately $11.8 million and accumulated deficit of approximately $224.9 million. Net cash used in operations was $3,291,571, partially offset by $4,144,303 provided by financing activities, including equity and warrant-related issuances. Management discloses that these conditions raise substantial doubt about the company’s ability to continue as a going concern and is evaluating strategic alternatives, including potential mergers, sales, wind-down or bankruptcy.
GridAI Technologies Corp. reported that it cannot file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026 within the prescribed time due to delays in obtaining and compiling required information. The company is using a Rule 12b-25 extension and expects to file within five calendar days of the original due date. It states that all other required periodic reports over the past 12 months have been filed and that it does not anticipate any significant change in results of operations versus the same quarter of the prior year.
GridAI Technologies Corp. has filed an amended resale registration covering up to 9,908,766 shares of common stock, all to be sold by existing stockholders from Common Shares and warrants issued in May and July 2026 private placements. GridAI combines an AI-focused grid-optimization software business with a legacy Adrulipase biopharma program, both still in development.
The company will not receive proceeds from these resales, but may receive cash if investors exercise registered warrants. It reports cash and equivalents of $386,000 as of March 31, 2026 and a forecast annual cash burn of about $7.8 million. Together with roughly $4 million already received and an additional $12.3 million committed from the 2026 financings, management currently expects to fund planned operations for at least the next eighteen months, based on assumptions that may change.
Auditors have issued going concern opinions, and disclosures state that failure to secure capital or achieve effectiveness of this registration could force severe operational cuts, restructuring, or bankruptcy. GridAI also quantifies substantial potential dilution for existing holders from full warrant exercises and from possible future conversion of Series H preferred stock.
GridAI Technologies Corp. entered into a material agreement under which it made a $2,000,000 Secured Convertible Promissory Note loan to Pronghorn Resources, LLC on July 17, 2026. The Note bears 7% annual interest and is payable on the earlier of December 31, 2026 or the consummation of a defined Change of Control Transaction of Pronghorn.
The Note is secured by a lien on all of Pronghorn’s assets under a separate Security Agreement and ranks pari passu with Pronghorn’s existing indebtedness. Pronghorn agreed to restrictive covenants limiting additional indebtedness, liens and related agreements. If an Event of Default occurs and remains uncured, GridAI may declare the Default Amount immediately due in cash and, at its election, convert the applicable amount into membership interests equal to 10% of Pronghorn’s fully diluted capitalization as of the conversion date.
GridAI Technologies Corp. filed a notice of exempt securities offering for $8,500,000 USD of equity and related securities under Regulation D Rule 506(b). The company indicates that the full offering amount has been sold, with $0 USD remaining to be sold.
The issuer states that 5% of the gross proceeds will be paid to the company at closing and the remaining 95% will be paid before the SEC declares a registration statement effective. GridAI is a Delaware corporation organized more than five years ago and elected to decline disclosure of its revenue or asset size.
GridAI Technologies Corp. is registering 9,908,766 shares of common stock for resale by investors from its May and July 2026 private placements. The company itself will not receive proceeds from these sales, though it may receive cash if outstanding warrants are exercised.
GridAI operates a dual business: an energy orchestration and grid-optimization software platform for AI data centers through Grid AI Corp., and legacy biopharmaceutical development focused on Adrulipase. It has incurred significant losses, with an accumulated deficit of about $212.1 million and cash of $386,000 as of March 31, 2026, and its auditors have raised substantial doubt about its ability to continue as a going concern.
Recent private placements total roughly $7.8 million in May 2026 and $8.5 million in July 2026, much of which is payable before this registration becomes effective and tied to pre-funded and common warrants. The filing highlights that failure to secure additional financing or effectiveness of this registration by January 2027 could force the company to curtail or cease operations, pursue liquidation, or seek bankruptcy protection. It also discloses that if its Series H Preferred Stock becomes convertible, up to 38,801,546 new common shares could be issued, which would significantly dilute existing stockholders relative to the 6,913,241 shares outstanding as of July 2, 2026.
GridAI Technologies Corp. Chief Executive Officer Jason David Sawyer reported beneficial ownership of 540,000 shares of common stock, representing about 7.1% of the company’s outstanding shares. The position is primarily from restricted stock units granted under GridAI’s equity incentive plan, which vested across late 2025 and the first half of 2026.
Sawyer states the shares were acquired for investment purposes and that he will continually evaluate the position. He is engaged in discussions with other stockholders, officers, directors and third parties about GridAI’s operations and strategic direction, which could potentially involve capital raising, acquisitions, mergers or other strategic transactions, though he reports no definitive plans at this time.